Psychedelic

Courtney Barnes, a partner at Feldman Legal Advisors, advocate for psychedelic policy reform and upcoming guest at the Benzinga Cannabis Capital Conference positioned herself at the front lines of the legal landscape for cannabis and psychedelics, steering the conversation around regulation and...

Recent advancements within the field of mental health with the use of psilocybin-assisted therapy, as well as Colorado’s forward-thinking legislation about this therapy, have proven exciting. Psilocybin-assisted therapy showcased promising results in treating Generalized Anxiety Disorder (GAD...

In August, a group of well-known biotech institutional investors participated in an up to almost $300 million financing round for COMPASS Pathways (NASDAQ: CMPS), consisting of an initial investment of $125 million and the potential for an additional investment of up to $160 million if the...

Tesla CEO and Twitter Owner Elon Musk took a dig at Apple's new $3,500 augmented reality headset on Thursday. What Happened: Musk put out a meme on Twitter that featured a woman wearing the Vision Pro headset and some mushrooms that can "chemically" change your "carbon vibrations." The mushrooms...

Elon Musk shared his take on Adderall, a medication that is used to treat attention deficit hyperactivity disorder, or ADHD, on Sunday. What Happened: Musk said in response to a post on Twitter, "Adderall is an anger amplifier. Best used sparingly or not at all." Adderall is an anger amplifier....

The people of the future may not have to do much to get high or indeed have to pay through their noses to do so provided Twitter owner Elon Musk is correct. What Happened: Musk interacted with writer and illustrator Tim Urban on Twitter. Urban said the people of the future will simply go to an app...

Rep. Tony Lovasco (R) from Missouri filed a bill on Tuesday that would legalize the use of psychedelics for therapeutic use at designated care facilities and decriminalize low-level possession, reported Marijuana Moment. The bill would provide patients with certain serious conditions like treatment...

Compass Pathways PLC (NASDAQ: CMPS) is often viewed as the leader in the psychedelic sector with smaller companies such as Mind Medicine (OTC: MMEDF) and Mydecine Innovations Group Inc (OTC: MYCOF) often following its moves. After reaching an all-time high of $61.69 on Dec. 14, Compass Pathways...